Tanaka M - Search Results

1

HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody.

Tanaka M, Tanaka K. Tanaka M, et al. Among authors: tanaka k. Neurology. 1996 Aug;47(2):606-7. doi: 10.1212/wnl.47.2.606. Neurology. 1996. PMID: 8757056 No abstract available.

2

[A case of paraneoplastic cerebellar degeneration with resting tremor].

Kurokawa T, Taniwaki T, Arakawa K, Kikuchi H, Yao T, Tanaka K, Tanaka M, Yamada T, Kira J. Kurokawa T, et al. Among authors: tanaka m, tanaka k. Rinsho Shinkeigaku. 2001 Jan;41(1):24-30. Rinsho Shinkeigaku. 2001. PMID: 11433763 Japanese.

3

Antibodies to brain proteins in a patient with subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome.

Tanaka K, Tanaka M, Miyatake T, Yamamoto A, Kurahashi K, Matsunaga M. Tanaka K, et al. Among authors: tanaka m. Tohoku J Exp Med. 1987 Oct;153(2):161-7. doi: 10.1620/tjem.153.161. Tohoku J Exp Med. 1987. PMID: 3686524 Free article.

4

Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration.

Tanaka K, Tanaka M, Onodera O, Igarashi S, Miyatake T, Tsuji S. Tanaka K, et al. Among authors: tanaka m. J Neurol Sci. 1994 Dec 20;127(2):153-8. doi: 10.1016/0022-510x(94)90067-1. J Neurol Sci. 1994. PMID: 7707074

5

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.

Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Tanaka K, et al. Among authors: tanaka m. Clin Neurol Neurosurg. 1995 Feb;97(1):101-5. doi: 10.1016/0303-8467(95)00006-6. Clin Neurol Neurosurg. 1995. PMID: 7788964

6

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.

Tanaka M, Tanaka K, Onodera O, Tsuji S. Tanaka M, et al. Among authors: tanaka k. Clin Neurol Neurosurg. 1995 Feb;97(1):95-100. doi: 10.1016/0303-8467(95)00005-5. Clin Neurol Neurosurg. 1995. PMID: 7788981

7

Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.

Tanaka K, Tanaka M, Igarashi S, Onodera O, Nakajima T, Yamazaki M, Miyatake T, Tsuji S. Tanaka K, et al. Among authors: tanaka m. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):256-7. doi: 10.1136/jnnp.58.2.256. J Neurol Neurosurg Psychiatry. 1995. PMID: 7876871 Free PMC article. No abstract available.

8

[The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].

Tanaka K, Tanaka M, Onodera O, Igarashi S, Tsuji S. Tanaka K, et al. Among authors: tanaka m. No To Shinkei. 1994 Jan;46(1):47-51. No To Shinkei. 1994. PMID: 8136199 Japanese.

9

Anti-Yo antibody binding to 62-, 52-, or 58-kd protein recognizes a single molecule.

Tanaka K, Tanaka M, Tsukamoto T, Uehara T, Tsuji S. Tanaka K, et al. Among authors: tanaka m. Neurology. 1996 Jun;46(6):1777-8. doi: 10.1212/wnl.46.6.1777. Neurology. 1996. PMID: 8649596 No abstract available.

10

[Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].

Tanaka K, Tanaka M, Onodera O, Tsuji S. Tanaka K, et al. Among authors: tanaka m. Rinsho Shinkeigaku. 1995 Jul;35(7):770-4. Rinsho Shinkeigaku. 1995. PMID: 8777801 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,439 results

Search Page

Filters